Theodore H. Stanley, Director at Insys Therapeutics, Inc. (INSY), bought 500 shares at $36.15 ($18K) on 2013-12-13, disclosed to the SEC on 2013-12-13.
Open-market purchase of $18k INSY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| INSY | SELL | 2016-03-04 | $362K | — | Filing → |
| INSY | SELL | 2015-09-14 | $148K | — | Filing → |
| INSY | SELL | 2015-03-10 | $198K | — | Filing → |